These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 31520364

  • 1. Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
    Vedovati MC, Mosconi MG, Isidori F, Agnelli G, Becattini C.
    J Thromb Thrombolysis; 2020 Feb; 49(2):251-258. PubMed ID: 31520364
    [Abstract] [Full Text] [Related]

  • 2. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A, Meyer Dos Santos S, Ferreirós N, Labocha S, Meyer Dos Santos IM, Picard-Willems B, Harder S, Singer OC.
    Thromb Haemost; 2017 Feb 28; 117(3):519-528. PubMed ID: 28124061
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A, Norberg EM, Berndtsson M, Rasmuson A, Malmström RE, Skeppholm M, Antovic J.
    Thromb Haemost; 2017 Aug 30; 117(9):1700-1704. PubMed ID: 28640321
    [Abstract] [Full Text] [Related]

  • 5. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
    Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.
    J Thromb Haemost; 2016 Nov 30; 14(11):2194-2201. PubMed ID: 27566988
    [Abstract] [Full Text] [Related]

  • 6. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.
    Mahamad S, Chaudhry H, Nisenbaum R, McFarlan A, Rizoli S, Ackery A, Sholzberg M.
    J Thromb Thrombolysis; 2019 Feb 30; 47(2):272-279. PubMed ID: 30506352
    [Abstract] [Full Text] [Related]

  • 7. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P.
    Thromb Haemost; 2016 Aug 01; 116(2):235-40. PubMed ID: 27075441
    [Abstract] [Full Text] [Related]

  • 8. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G.
    J Thromb Haemost; 2018 May 01; 16(5):842-848. PubMed ID: 29532628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e009807. PubMed ID: 30371316
    [Abstract] [Full Text] [Related]

  • 11. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T, Flieder T, Fox V, Gripp T, Dittrich M, Kuhn J, Alban S, Knabbe C, Birschmann I.
    Eur J Cardiothorac Surg; 2017 Apr 01; 51(4):624-632. PubMed ID: 28043992
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
    Gouin-Thibault I, Freyburger G, de Maistre E, Susen S, Delavenne X, Golmard JL, Gruel Y, Sié P, GFHT study group on DOAC.
    Thromb Res; 2017 Oct 01; 158():126-133. PubMed ID: 28892657
    [Abstract] [Full Text] [Related]

  • 19. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.
    Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G, Coordinator of START2-Register.
    J Thromb Haemost; 2019 Jul 01; 17(7):1064-1072. PubMed ID: 31013383
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.